I dont think that there is any reason to be alarmed, I'm certainly not. The results of the Aussie trials are long overdue, but they seem reasonable and in line with FDA requirements. All the speculation out there is because they measured them in a different way, in fact way too much concern IMO. However we are getting to the business end of the fact finding, and its about results that will be accepted by FDA. Of course it would be better if we all knew the detailed hurdle but we dont. It seems it could have some subjectivity rather be a binary "it passed or not" type of test.
As for positive reaction, lots of people still here and holding proportionately large amounts. FIL still accumulating, they are circa 10% and buying at recent levels means they have spent close to $20m for their stake. I think my stake is big but thats one hell of a gamble, and they aren't selling down but buying up.
- Forums
- ASX - By Stock
- Ann: ResApp Provides Updated Australian Paediatric Study Results
I dont think that there is any reason to be alarmed, I'm...
-
- There are more pages in this discussion • 112 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
GML
Gateway Mining sells WA Eastern Montague gold project to Brightstar for $14M – half of that in shares
MTL
Mantle Minerals' Nick Poll talks to HotCopper on finding gold grades up to 3.57g/t at Mt Berghaus
Add RAP (ASX) to my watchlist
|
|||||
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $176.2M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
GML
Gateway Mining sells WA Eastern Montague gold project to Brightstar for $14M – half of that in shares
AVH
Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin
RAP (ASX) Chart |
Day chart unavailable